Literature DB >> 24413994

MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN.

Rong Li1, Jun-Lin He, Xue-Mei Chen, Chun-Lan Long, De-Hui Yang, Yu-Bin Ding, Hong-Bo Qi, Xue-Qing Liu.   

Abstract

Abnormal cell proliferation is a main driver of tumor formation and development, which involves the deletion, mutation, and downregulation of tumor suppressor genes. One study recently demonstrated that miR-200a plays an oncogenic role by inhibiting phosphatase and tensin homolog deleted on chromosome ten (PTEN) expression. In the human endometrial adenocarcinoma cell line HEC-1B, suppression of miR-200a expression inhibited cell proliferation and promoted apoptosis, whereas its over-expression had no effect on proliferation and apoptosis. Furthermore, inhibition or over-expression of miR-200a increased or reduced the expression of PTEN, respectively, with no change in PTEN mRNA levels. These effects were achieved by directly targeting miR-200a to the 3' untranslated region of the PTEN mRNA to inhibit its translation. Taken together, we propose that in HEC-1B cells, miR-200a functions as an oncogene, affecting proliferation and apoptosis by regulating the expression of the tumor suppressor PTEN at the translational level.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24413994     DOI: 10.1007/s11033-014-3045-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

1.  Hypermethylation of the PTEN gene in ovarian cancer cell lines.

Authors:  Thomas Schöndorf; Matthias P Ebert; Juliane Hoffmann; Martina Becker; Natasha Moser; Saziye Pur; Uwe-Jochen Göhring; Maria-Paz Weisshaar
Journal:  Cancer Lett       Date:  2004-04-30       Impact factor: 8.679

2.  A high-throughput method to monitor the expression of microRNA precursors.

Authors:  Thomas D Schmittgen; Jinmai Jiang; Qian Liu; Liuqing Yang
Journal:  Nucleic Acids Res       Date:  2004-02-25       Impact factor: 16.971

3.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

4.  NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.

Authors:  Xinjiang Wang; Lloyd C Trotman; Theresa Koppie; Andrea Alimonti; Zhenbang Chen; Zhonghua Gao; Junru Wang; Hediye Erdjument-Bromage; Paul Tempst; Carlos Cordon-Cardo; Pier Paolo Pandolfi; Xuejun Jiang
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

5.  Differentiation of endometrial stromal cells in vitro: down-regulation of suppression of the cell cycle inhibitor p57 by HOXA10?

Authors:  Kun Qian; Hong Chen; Yulan Wei; Juan Hu; Guijin Zhu
Journal:  Mol Hum Reprod       Date:  2005-03-04       Impact factor: 4.025

6.  Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.

Authors:  Xiaojuan Yan; Michael Fraser; Qing Qiu; Benjamin K Tsang
Journal:  Gynecol Oncol       Date:  2006-03-20       Impact factor: 5.482

7.  Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas.

Authors:  Eri Hiroki; Jun-Ichi Akahira; Fumihiko Suzuki; Satoru Nagase; Kiyoshi Ito; Takashi Suzuki; Hironobu Sasano; Nobuo Yaegashi
Journal:  Cancer Sci       Date:  2009-10-08       Impact factor: 6.716

8.  MicroRNAs in human cancer: from research to therapy.

Authors:  Massimo Negrini; Manuela Ferracin; Silvia Sabbioni; Carlo M Croce
Journal:  J Cell Sci       Date:  2007-06-01       Impact factor: 5.285

Review 9.  Management of advanced-stage and recurrent endometrial cancer.

Authors:  Mandira Ray; Gini Fleming
Journal:  Semin Oncol       Date:  2009-04       Impact factor: 4.929

10.  miRGen: a database for the study of animal microRNA genomic organization and function.

Authors:  Molly Megraw; Praveen Sethupathy; Benoit Corda; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2006-11-15       Impact factor: 16.971

View more
  10 in total

1.  The role of miR-200a in mammalian epithelial cell transformation.

Authors:  Lindsey E Becker; Apana Agha L Takwi; Zhongxin Lu; Yong Li
Journal:  Carcinogenesis       Date:  2014-09-19       Impact factor: 4.944

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

Review 3.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

4.  MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells.

Authors:  Lourdes Sánchez-Cid; Mònica Pons; Juan José Lozano; Nuria Rubio; Marta Guerra-Rebollo; Aroa Soriano; Laia Paris-Coderch; Miquel F Segura; Raquel Fueyo; Judit Arguimbau; Erika Zodda; Raquel Bermudo; Immaculada Alonso; Xavier Caparrós; Marta Cascante; Arash Rafii; Yibin Kang; Marian Martínez-Balbás; Stephen J Weiss; Jerónimo Blanco; Montserrat Muñoz; Pedro L Fernández; Timothy M Thomson
Journal:  Oncotarget       Date:  2017-09-07

5.  Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway.

Authors:  Shudan Mao; Jieping Jin; Zhe Li; Wenqi Yang
Journal:  Mol Med Rep       Date:  2020-12-16       Impact factor: 2.952

6.  CircRNA75 and CircRNA72 Function as the Sponge of MicroRNA-200 to Suppress Coelomocyte Apoptosis Via Targeting Tollip in Apostichopus japonicus.

Authors:  Jiqing Liu; Xuelin Zhao; Xuemei Duan; Weiwei Zhang; Chenghua Li
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

Review 7.  The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.

Authors:  Ilaria Cavallari; Francesco Ciccarese; Evgeniya Sharova; Loredana Urso; Vittoria Raimondi; Micol Silic-Benussi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

Review 8.  The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.

Authors:  Brock Humphries; Chengfeng Yang
Journal:  Oncotarget       Date:  2015-03-30

9.  A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.

Authors:  Xian Wang; Shan Huang; Xiaocan Li; Dongrui Jiang; Hongzhen Yu; Qiang Wu; Chaobing Gao; Zhengsheng Wu
Journal:  PLoS One       Date:  2018-07-13       Impact factor: 3.240

Review 10.  The emerging role of super enhancer-derived noncoding RNAs in human cancer.

Authors:  Yutong Wang; Hui Nie; Xiaoyun He; Zhiming Liao; Yangying Zhou; Jianhua Zhou; Chunlin Ou
Journal:  Theranostics       Date:  2020-09-02       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.